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Background: Catheter securement is critical for the success of infusion therapy and
to prevent complications. Our purpose was to compare the strength of catheter
securement achieved with two investigational adhesive securement devices to two
securement products and also to sutures using an in vivo animal model.
Methods: Twenty-five live pigs were prepared for aseptic abdominal surgery. Four
central venous catheters were inserted per animal into the epigastric veins and
secured with four of the five securement systems studied, following a balanced
incomplete randomized block design. A peak axial pull force test method was used
to measure the force required to dislodge the catheter 1 cm from the insertion site
and/or cause failure of the device and/or dressing. This pull test was done 10 min
after device application, per constraints of the animal model. Comparison analysis
was carried out using a mixed effects model with pig, sample, and sample location
as factors. Non-inferiority testing was carried out using 95 % confidence intervals
with a margin of 4.52 N or 1 lb (454 g). Tukey’s method was used to adjust for
multiple pairwise comparisons.
Results: Results showed that the two investigational devices displayed the highest
mean peak axial pull forces (40–41 N) and were significantly better than sutures
(28 N, p < 0.0001) and the securement dressing (17 N, p < 0.0001) and non-inferior to
the securement device (37 N) in this test. The securement device required a higher
mean peak axial pull force than sutures (p = 0.0007) and the securement dressing
(p < 0.0001) for failure to occur. Finally, there was also a statistical difference between
sutures and the securement dressing, with sutures requiring a higher mean peak
axial pull force for catheter dislodgement than the securement dressing (p < 0.0001).
Conclusion: The two investigational devices appear to be a promising alternative for
catheter securement, superior to sutures and the securement dressing, and
non-inferior to the securement device.
Keywords: Catheters; Central venous catheters; Peripheral venous catheterization;
Models; Animal; Dressings; Intravenous administration; Vascular access devices;
Catheter securement2015 Rutledge et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International
icense (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium,
rovided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
ndicate if changes were made.
Rutledge et al. Intensive Care Medicine Experimental  (2015) 3:24 Page 2 of 14Background
Catheter securement is essential to the success of short-term (<10 days), non-
tunneled central venous catheter (CVC) infusion therapy. These short-term CVCs
provide an avenue for various therapies, namely the delivery of medications and
solutions that cannot be safely infused into the peripheral circulation, fluid resuscita-
tion, repeated blood product replacement, short-term hemodialysis, and the monitor-
ing of hemodynamic status [1]. If these catheters are not effectively secured to the
skin, they can become displaced, causing a wide range of complications and safety
issues [2, 3]. The various factors affecting catheter securement have been recently
reviewed [4].
Catheter securement can be accomplished using several different methods. The
most frequently used method of securing short-term CVCs to the skin is silk or nylon
sutures [2, 5, 6]. However, the use of sutures is associated with needlestick or sharp
injuries to the health-care worker, as well as patient discomfort and the consequences
related to disrupting the patient’s skin barrier [7]. To address these issues, manufac-
tured catheter stabilization devices have entered the market in the last decade and are
gaining in acceptance to provide securement [8]. Since 2006, various guidelines
recommend the use of such securement devices [1, 8–10]. A recent literature review
also found that securement with adhesive systems is more effective than suturing to
reduce blood stream infections [11]. Yet, changing practice in health care can take a
long time and physicians are likely to continue using sutures for securing CVCs until
a larger body of evidence exists for an effective alternative.
To generate evidence comparing sutureless catheter securement methods to
sutures, a pig model was used so catheters could be inserted into a dynamic system
while avoiding the ethical issues associated with the use of a human model. A peak
axial pull force test method was used to determine the relative strength of each
securement system in preventing dislodgement under a constant axially directed
force. The objective of this study was to explore the catheter securement performance
of two novel sutureless systems compared to commercially available sutureless cath-
eter securement systems and sutures. We hypothesized that the novel securement




The following securement systems were applied to the inserted catheters per ran-
domization schedule and manufacturer’s application instructions. The samples were
allowed to dwell on the skin for 10 min prior to testing.
Test materials (commercially available at the time of the experiments):
 Securement device: StatLock® stabilization device (Bard PICC Plus Stabilization
Device, Item #VPPCSP, Bard Medical, Covington, GA, USA), covered with a
bordered IV cover dressing (3M™ Tegaderm™ Transparent Film Dressing with
Border cat.1655, 3M Company, St. Paul, MN, USA).
 Securement dressing: SorbaView® SHIELD dressing (Cat. # SV353 UDT, Centurion,
Williamston, MI, USA).
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cover dressing (3M™ Tegaderm™ Transparent Film Dressing with Border cat.1655,
3M Company, St. Paul, MN, USA).
Investigational materials
 Investigational device 1: 3M™ PICC/CVC Securement device + 3M™ Tegaderm™ IV
Advanced Securement Dressing (Cat. #1837-2100, 3M Company, St. Paul, MN,
USA): a catheter securement device coated with a silicone adhesive and a plastic
retainer used to stabilize the catheter lumens, covered with a bordered dressing.
This product was under development at the time of this experimentation and is
now commercially available.
 Investigational device 2: 3M™ PICC/CVC Securement device + 3M™ Tegaderm™
CHG Chlorhexidine Gluconate IV Securement Dressing (Cat. # 1877-2100, 3M
Company, St. Paul, MN, USA): identical to device 1 but covered with a bordered
dressing containing a chlorhexidine gluconate (CHG) gel pad.Animal model and catheter insertion technique
This study was approved by the contract lab (Synchrony Labs) institutional animal care
and use committee and animal care complied with the Guide for the Care and Use of
Laboratory Animals and the Animal Welfare Act (9CFR). A pig model was developed by
adapting a validated internal test method involving un-inserted catheters placed on the
back of humans. This method was modified for use on the pig to include insertion of
catheters into the epigastric veins. The investigators were first trained on the validated
method prior to proceeding with the animal experiments described below. Training
entailed generating peak axial pull force measurements of cut (or un-inserted) catheters
placed on the back of a pig using four out of the five study materials (sutures excluded).Pig model
The study used 26 large female farm pigs (48 ± 3 kg) obtained from Palmetto Research
Swine (Reevesville, SC, USA) and was completed in the surgical suite of a facility specializ-
ing in pre-clinical models (Synchrony Labs, Durham, NC, USA). The pigs were sedated
with Telazol® (4–6 mg/kg) prior to the procedure, and general anesthesia was induced
using 5 % isoflurane dispensed through a face mask and maintained with 2–2.5 % isoflur-
ane via endotracheal tube. Animals were placed on the surgery table in dorsal recumb-
ence. Standard ECG leads were applied, and a venous catheter was placed for infusion of
fluids in the ear, a location away from the test sites. The animals were intubated, anesthe-
tized, and ventilated prior to testing and were prepared for aseptic abdominal surgery
using a standard procedure. The hair on the abdomen was removed using an animal clip-
per with a #40 blade, and the area was washed with water only. The abdomen was then
wiped with 70 % isopropyl alcohol (IPA). Each insertion site on the abdomen was
scrubbed with a 10.5 ml, clear ChloraPrep® Patient Preoperative Skin Preparation (Care-
Fusion, San Diego, CA, USA), a 2 % chlorhexidine gluconate/70 % isopropyl alcohol for-
mulation. The ChloraPrep® was allowed to air-dry for at least 5 min to ensure optimal
adhesion of the products to skin. In the case of the securement device, the skin was
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During the procedure, animals were monitored for the presence of spontaneous move-
ment and blood oxygen saturation and if needed, appropriate adjustments to anesthesia
were made. At the end of the procedure, the animals were given a dose of 40 mEq IV of
potassium chloride (KCl) and removed from the ventilator following the American Veter-
inary Medical Association guidelines on euthanasia [12].Catheter insertion
A triple lumen 7 Fr., 16-cm-long Arrow®-Howe’s Multi-Lumen Central Venous Catheter
(Teleflex® Inc., Research Triangle Park, NC, USA) was aseptically inserted into one of four
insertion sites of the superficial epigastric veins and spaced to allow one catheter per loca-
tion in the right and left upper abdomen and right and left lower abdomen. Insertions were
performed using a longitudinal “cut-down” technique to surgically expose the epigastric
vein and insert the catheter into the vein under direct vision. The catheter tip was directed
toward the animal’s head so that the catheter lumens could be directed caudally.
In order to provide enough space between securement systems, only two catheters were
inserted at one time and placed diagonally from one another, e.g., right cranial and left
caudal aspects of the abdomen as illustrated in Fig. 1. The skin where each catheter exited
was marked with an indelible skin marker. After the first set of two catheters and secure-
ment systems were tested, they were pulled out and the second set of two catheters and
securement systems were positioned and tested (left cranial, right caudal).Fig. 1 Schematic view of the pig abdomen with two catheters inserted (right cranial, left caudal)
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Figure 2 provides illustrations of the various devices and how they were applied, as
modeled on a flat surface for better photographic results. For each device, the first
photograph shows the fixation device itself and the second photograph illustrates the
device covered with the appropriate dressing. Each device that was not a dressing was
covered to comply with its instructions for use to ensure the most clinically relevant
test result. For the investigational devices, the first photo shows the fixation device
itself, the second photo shows it covered with the dressing without the CHG pad, and
the third photo shows the fixation device covered with the CHG dressing.
For the securement device (Fig. 2a) and the securement dressing (Fig. 2b), the manu-
facturer’s instructions were followed. The securement device was covered by a bordered
film dressing (3M™ Tegaderm™ Transparent Film Dressing with Border).
Suturing technique (Fig. 2c): To anchor the catheter to the skin, a 3–0 silk suture on
a curved needle was first passed through approximately 5-10 mm of skin under each of
the two catheter eyelets. After a square knot was tied, the suture was then threaded
through each catheter eyelet and three interlocking square knots were made using a
needle driver. A dressing was used to cover the insertion site and sutures.
For the investigational systems (Fig. 2d), which consisted of both a device and a
dressing, the following application method was used.
First photo: The device was oriented with arrows pointing toward the insertion site.
The catheter was placed into the device, and the lumens were woven under the single
plastic arm. A large, notched, film-covered soft cloth tape strip is included in the
system. The liner of the attached tape strip was removed, and the lumens were secured
to the device base by the tape strip. The device was positioned on the skin at theFig. 2 Application of the investigational materials. a Securement device. b Securement dressing. c Sutures.
d Investigational devices 1 and 2. For each device, the first photo shows the fixation device itself, and the
second photo shows the final result after the device is covered with the appropriate dressing. For the
investigational devices, the first photo shows the fixation device itself, the second photo shows it covered
with the dressing without the CHG pad, and the third photo shows the fixation device covered with the
CHG dressing
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device base to establish good adhesion to the skin.
Second photo (investigational device 1): After application of the device, 3M™ Tegaderm™
IV Advanced Securement dressing was applied by peeling the liner and placing the dress-
ing so the transparent film covered the insertion site and the border of the dressing cov-
ered the single plastic arm on the device. Firm pressure was applied on the dressing
including edges to enhance adhesion to the skin. The frame was removed slowly while
smoothing down the dressing edges and pressing from the center toward the edges to en-
hance adhesion. The sterile tape strip was then applied by removing the liner, grasping
the non-adhesive tab, and bending slightly with the thumb. The catheter lumens were
lifted and the notch end of the tape strip was applied under the lumens and over the
dressing edge. Pressure was applied on the tape strip to enhance adhesion. The frame was
then removed from the tape strip.
Third photo (investigational device 2): The dressing used to cover the device is 3M™
Tegaderm™ CHG Chlorhexidine Gluconate IV Securement Dressing.
Catheter preparation for testing
To attach the catheter to the IMASS pull tester, the three lumens were clamped and a loop
was created by tying the outer two lumens together in a half knot at their distal ends. To
prevent the knot from unraveling, a narrow strip of tape was applied to encircle the knot.
The IMASS machine was positioned at the foot of the O.R. table, and the “s” hook on the
end of the IMASS connection cable was attached to the catheter loop created earlier. This
is illustrated in Fig. 3. Using a bubble level attached to the IMASS connection wire, the
height of the IMASS table was adjusted so that the IMASS connection wire was axial (level)
to the catheter insertion site from which the catheter was pulled.Fig. 3 Lumens tied in a knot and taped; IMASS hook placement on lumens for pull test
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The peak axial pull force test was used to measure catheter securement. In this study,
catheter securement was defined as the peak force (N) obtained when either of the
following failure events occurred (whichever came first):
 The catheter moves 1 cm or greater out of the insertion site (this amount of
motion is clinically relevant as catheter tip migration from the cavo-atrial junction
can lead to significant complications in a clinical setting [9])
 The dressing and/or device lifts off the skin
 The catheter pulls out from under the dressing
 The doors of the securement device open
 The sutures break
The peak axial pull force was measured using an IMASS Model SP-2100 Slip/Peel
Tester (IMASS Inc, Accord, MA, USE). The raw peak axial pull force was collected in
the units of gram-force, which was converted to the SI unit of Newton using the
following formula: 1 g-force = 0.00980665 Newton (N). For comparison, a force of 40 N
corresponds to 9 lbs (4.82 kg) of force. The system is described in Fig. 4. Ten minutes
after the application of the securement system, the video recording of the entire pull
force profile was started, and the pull force (tensile distraction force) was applied at the
rate of 76.2 cm/min (30 in./min). The peak axial pull force measurement was obtained
when securement system failure occurred. The peak axial pull force (securement of the
catheters) was recorded for each securement system applied to each pig. Video record-
ing of the entire pull force profile was obtained and later reviewed. Once peak axial pull
force testing was completed with the first two catheters, those were removed, manual
pressure was applied to the sites to control bleeding, and the other two insertion sites
were accessed. The peak axial pull test method was then repeated for the other two
catheters.Fig. 4 Peak axial pull force test equipment
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A sample size of 25 (no replicates per product on the pig) was planned in this study
based on a power calculation. This sample size would achieve at least 80 % power to
detect a difference of 454 gram force or 4.45 N (using an adjusted Tukey test) if the
within-pig standard deviation (SD) was at most 420 gram force (4.12 N), assuming
94 % efficiency with the incomplete block design of having five samples to choose from
with a maximum of four samples per pig.
Peak axial pull force analysis was conducted using a mixed effects model at significance
level of 0.05 (two-sided). Sample and sample location (upper versus lower sites) were used
as the fixed effects in the model, while subject (pig identifier) was included in the model
as the random effect. The sample-by-location interaction term was tested for significance.
Heterogeneity was modeled in which each sample was allowed a different covariance
parameter.
Non-inferiority/superiority testing was carried out using the two-sided 95 % adjusted
confidence limits and the margin of 4.45 N or 1.0 lb force or 454 gram force. Tukey’s
method was used to adjust for multiple pairwise comparisons, which were based on the
differences in least squares means.
Results
Reproducibility of model
Protocol deviations with respect to sample placement occurred with two early pigs such
that there were only three products placed instead of the expected eight products. An
additional pig was utilized to obtain four out of the five missing products. This created
an imbalance in the placement of sutures and the investigational device 1 samples.
Table 1 displays the number of replicates and location for each system tested. The 26
pigs provided a total of 99 sites. The overall sample size consisted of 20 data points for
all samples except sutures in which 19 data points were recorded. Table 2 provides the
summary of the data collected for each device tested along with information on the
reproducibility of this test method.
The sample-by-location interaction term was non-significant. The final model
chosen included just the main effects of sample and location (upper vs lower inser-
tion sites). Based on the final model, the within-pig SD was estimated at 0.99 N and
the between-pig SD was estimated between 5.16 and 6.91 N, with the securement
dressing having the lowest SD and investigational device 1 having the highest SD.
Performance of the securement systems
All systems had the same mode of failure, which was the movement of the catheter









Upper right sites 6 5 5 5 5
Upper left sites 5 5 4 5 5
Lower right sites 4 5 5 5 5
Lower left sites 5 5 5 5 5
All sites 20 20 19 20 20
Table 2 Summary statistics of peak axial pull force dataset
Sample Peak axial pull force (Newton)
N Mean SD Median Min Max
Investigational device 1 20 40.41 6.976 40.61 28.42 50.71
Investigational device 2 20 41.01 6.548 40.55 31.99 57.32
Sutures 19 27.56 6.443 26.27 19.06 45.21
Securement device 20 36.98 6.833 37.57 23.70 47.29
Securement dressing 20 17.44 5.453 16.18 10.96 30.73
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forces for all methods of securement compared in this study.
Results showed that the two investigational devices displayed the highest mean peak
axial pull forces (40–41 N) and were significantly better than sutures (28 N, p < 0.0001)
and the securement dressing (17 N, p < 0.0001) and non-inferior to the securement
device (37 N) in this test (Fig. 5). Both investigational systems 1 and 2 were estimated
at 3.31 N (95 % CI −1.14, +7.76 N) and 4.03 N (95 % CI −0.28, +8.34 N) higher than
the securement device, respectively, and proved to be non-inferior to it based on the
lower 95 % confidence limit falling within the non-inferior margin (≥4.452 N).
The securement device required a higher mean peak axial pull force than sutures
(p = 0.0007) and the securement dressing (p < 0.0001) for failure to occur. Finally, the
difference in mean peak axial pull force between sutures and the securement dressing
also reached statistical significance (28 versus 17 N, p < 0.0001).Fig. 5 Mean peak axial pull force for each type of securement device (least squares, mean ± standard error).
Samples labeled with the same symbols are not significantly different from each other. Least squares means
differ slightly from the unadjusted means displayed in Table 2 due to the overall imbalance of securement
devices placed on pigs
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average differed from each other by less than 1 N (95 % confidence limits −5.05 N,
+3.62 N). Both investigational devices had means that were 12.7–13.4 N higher than
sutures and 22.9–23.6 N higher than the securement dressing.
Overall, both investigational devices were significantly better than sutures (50 % stronger),
significantly better than the securement dressing (140 % stronger), and non-inferior to the
securement device in this test method. None of these devices caused damage to the skin of
the animals. However, since the animals were under anesthesia during the whole procedure,
the catheter pull test was performed shortly after the application of the securement devices
and not several days later to simulate clinical wear time, which is a limitation of this model.
Discussion
Our results showed that the two investigational devices displayed the highest mean peak
axial pull forces (40–41 N) and were significantly better than sutures (28 N, p < 0.0001)
and the securement dressing (17 N, p < 0.0001) and non-inferior to the securement device
(37 N) in this test.
A growing body of clinical literature has described the use of securement (or
stabilization) devices and dressings for intravenous catheters in order to reduce complica-
tions. From this literature, StatLock® appears to be the most commonly studied sutureless
catheter securement device for CVCs [13–21]; other devices such as the Nexiva™ Closed
IV Catheter System with the customized 3M™ Tegaderm™ IV Advanced Securement
Dressing, the Sorbaview® dressings, the HubGuard® catheter securement dressings, and
the SecurAcath® device have also been the topic of research publications [22–26]. Catheter
securement reduces phlebitis, infection, catheter migration, and dislodgement (reviewed
in [13]). Other authors have published papers stating that securement devices help to
reduce catheter-related bloodstream infections (CR-BSIs) and suture-related needlesticks
and improve cost-effectiveness in patients with central venous access devices, including
peripherally inserted central catheters (PICCs) [7, 11]. The investigational devices we
describe here have not been tested for CR-BSI reduction at this time. The effect of secure-
ment on catheter complications has been reviewed from a clinical standpoint in [27].
These important clinical studies look at factors such as complication rates, ease of use,
dwell time, patient comfort, and cost but do not address the mechanical properties such
as pull force to compare the various products since it would be unethical to run such
experiments on patients.
Although catheter securement systems have been observed to be very useful in clin-
ical use, the rigorous, quantitative testing of their mechanical performance is still in its
infancy. Since it would be unethical to subject patients to the risks of tissue injury and
catheter dislodgement, models have been created for this type of testing, and they each
have their own limitations. For example, forces required to pull out catheters secured
with various tapes and taping methods have been measured with a force transducer
using a simulated forearm model consisting in PVC pipe [28]. The same group also
conducted experiments on the forearm of human volunteers, with catheters taped to
the skin but not inserted into veins. We have also used a similar method to test peak
axial pull force on human volunteers, in addition to performing a drop test to simulate a
fast pull [29]. Other researchers have used pig skin in vitro to suture a catheter adjacent to
the catheter entry site and suspend a 1 lb weight to check the tethering, but they have not
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mortem newborn pig hind legs were used to measure the pull force of catheters secured in
different ways (standard or bordered polyurethane films, StatLock®, or tissue adhesives) [31].
It was not specified however whether the catheters were inserted in a vein or just in the tis-
sue. They obtained a mean pull force of about 22 N for StatLock® in their model, versus a
mean value of about 37 N using our model, indicating differences between the models. They
did not use sutures as a comparator. A porcine hind limb model was also used to compare
catheterization techniques for peripheral nerve block and the resulting force required to
withdraw catheters, but no securement systems were tested in that study [32]. A different
group used the proximal end of discarded extremities after below-the-knee amputations to
serve as a surrogate tissue for catheter fixation [33]. In this study, a rod was used to tunnel
the catheter under the skin to simulate placement into a central vessel. They compared su-
tures to two types of staples and measured pull forces. The mean peak force required to dis-
lodge sutures was around 41 N (we were around 27 N in our model). Their study did not
test adhesive securement systems.
We have used our animal model to compare various adhesive systems to sutures in
the same set of experiments. We chose the pig because of the feasibility of inserting
catheters in blood vessels of a size comparable to those of humans and because pig skin
has been considered the most similar to humans among the non-primate animals for
decades in in vivo wound healing research [34, 35]. In addition, we believe that the
reaction of pig skin to adhesives is likely to model human skin because both species
have a similar total turnover time for the epidermis (30 days for the pig and 26–27 days
for humans) [36]. We believe that our model presents an advantage over the other
models from the literature, because the catheters were truly inserted into veins of living
(anesthetized) animals. The peak axial pull force values measured are therefore likely to
better approximate the clinical situation and provide a good basis for the comparison
of various securement devices. Since we also generated internal data using the same
pull force testing equipment on human volunteers (without insertion of the catheters
into veins and without the suture comparison), we are able to comment on the two
models. When comparing the pull force data generated in this pig model to the pull
force data generated in the human in vivo model, the values were higher in the pig
model than in the human model (the difference ranged on average from 4.6 to 9.2 N).
Factors related to a catheter being inserted in the veins and the skin of the pig (no
moisture or sweating compared to humans) may be contributing to the observed
differences in readings. As found in the pig study, the findings in our human study
had indicated that the securement dressing required significantly less force to dis-
lodge the catheter than all three of the sutureless securement systems tested, and
the three sutureless securement devices showed pull forces that were not different
from each other at every time point tested (5 min, 4, and 7 days; manuscript in
preparation). Therefore, the comparative performance of the adhesive securement
systems tested was the same in both models, confirming the relevance of the pig
model in effectively predicting the differences and similarities when measuring peak
axial pull force.
This study has some limitations. Since we used a model with animals under
anesthesia, the catheter pull test was performed shortly after the application of the se-
curement devices and not several days later to simulate clinical wear time. We also did
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plication. We chose to insert the catheters in epigastric vessels to reduce the number
of animals needed compared to using the jugular veins only. We do believe however
that our method is informative to compare various devices for their securement per-
formance after application. We chose the Bard StatLock® PICC Plus Stabilization De-
vice as a comparator because we had also used it in our human model without vein
insertion and already had comparative data. Moreover, this application is not contrain-
dicated in the instructions for use of this product. We believe our results are relevant
for both PICCs and CVCs since our model focuses on the performance of the device
when resisting a pull force. For our suture comparator, we selected one type of suture
and one fixation method, which may limit the generalizability of the comparison. The
possible disadvantages of the new systems are comparable to those of other adhesive
securement systems, such as pain or catheter migration while removing or replacing
the dressing, and possible skin irritation due to the adhesive on patients with sensitive
skin.Conclusions
In conclusion, the investigational systems were significantly better than sutures and the
securement dressing and non-inferior to the securement device in this pig model using a
pull force test method performed 10 min after application of the devices. Securement
devices specifically designed to house the catheter performed better than a dressing alone,
and such devices also performed better than sutures. Clinically, they offer the advantage
of avoiding additional skin perforations for patients as well as the risk of needlestick injur-
ies for health-care workers. The investigational sutureless catheter securement systems
described here will provide clinicians with viable securement alternatives to sutures and
other sutureless catheter securement systems, while offering the advantage of a conveni-
ent all-in-one system. Additional clinical benefits have been identified in a clinical user
survey study (manuscript in preparation).
The development of test methods that provide evidence not readily obtained in the
clinical setting is important to understand the fundamental mechanical properties of
these systems and to quantitatively compare their performance. Clinical studies de-
signed to compare the adverse events observed with various sutureless catheter secure-
ment systems will be needed to identify the clinically relevant differences between
these securement systems.
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